Hyloris Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Jun '25 Jun 27, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Market Capitalization	174	183	357	311	447	245	Upgrade
Market Cap Growth	-48.71%	-48.71%	14.84%	-30.44%	82.10%	-	Upgrade
Enterprise Value	151	157	319	260	402	187	Upgrade
Last Close Price	6.20	6.54	12.75	11.60	17.30	9.50	Upgrade
PS Ratio	17.79	18.76	94.97	130.24	144.35	1402.34	Upgrade
PB Ratio	5.40	5.70	9.14	5.77	9.30	4.16	Upgrade
P/TBV Ratio	5.71	6.03	10.13	5.97	9.67	4.26	Upgrade
EV/Sales Ratio	15.50	16.09	84.88	108.83	129.77	1068.71	Upgrade
Debt / Equity Ratio	0.06	0.06	0.05	0.02	0.18	0.14	Upgrade
Asset Turnover	0.22	0.22	0.07	0.04	0.05	0.01	Upgrade
Quick Ratio	4.12	4.12	5.14	8.32	3.53	30.33	Upgrade
Current Ratio	4.15	4.15	5.22	8.63	3.60	31.24	Upgrade
Return on Equity (ROE)	-17.81%	-17.81%	-33.08%	-23.35%	-21.62%	-29.24%	Upgrade
Return on Assets (ROA)	-8.94%	-8.94%	-18.27%	-11.58%	-9.73%	-8.44%	Upgrade
Return on Capital (ROIC)	-10.65%	-10.65%	-20.72%	-12.88%	-10.38%	-9.00%	Upgrade
Earnings Yield	-3.65%	-3.46%	-4.31%	-3.83%	-2.59%	-2.91%	Upgrade
FCF Yield	-3.99%	-3.79%	-3.67%	-4.22%	-2.54%	-1.86%	Upgrade
Buyback Yield / Dilution	-	-	-2.95%	-5.29%	-18.40%	-51.63%	Upgrade

Updated Oct 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.